Sociodemographic and clinicopathologic characteristics of patients treated with high dose rate prostate brachytherapy in nigeria

HIGHLIGHTS

• What: This study showed that the majority (79.5%) of the patients had a tertiary LOE and this was in tandem with the study done by Adewumi et al . The study showed that the median initial PSA was 26.0 ng/mL (range: 5.10-124.5 ng/mL) with 44 patients (60.3%) having PSA value greater than 20 ng/mL, which classifies them as high risk. Research Forty-six patients (63.0%) in the study had Gleason scores of 6 or 7 (Grade group 1-3) and this is similar to results from other studies . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.